Safety of Nanoparticles in Medicine
Wolfram, J; Zhu, MT; Yang, Y; Shen, JL; Gentile, E; Paolino, D; Fresta, M; Nie, GJ; Chen, CY; Shen, HF; Ferrari, M; Zhao, YL; Zhao YL(赵宇亮)
刊名CURRENT DRUG TARGETS
2015
卷号16期号:14页码:1671-1681
关键词Nanomedicine nanoparticle nanosafety nanotoxicity safety toxicity
学科分类Pharmacology & Pharmacy
DOI10.2174/1389450115666140804124808
通讯作者赵宇亮
文章类型Article
英文摘要Nanomedicine involves the use of nanoparticles for therapeutic and diagnostic purposes. During the past two decades, a growing number of nanomedicines have received regulatory approval and many more show promise for future clinical translation. In this context, it is important to evaluate the safety of nanoparticles in order to achieve biocompatibility and desired activity. However, it is unwarranted to make generalized statements regarding the safety of nanoparticles, since the field of nanomedicine comprises a multitude of different manufactured nanoparticles made from various materials. Indeed, several nanotherapeutics that are currently approved, such as Doxil and Abraxane, exhibit fewer side effects than their small molecule counterparts, while other nanoparticles (e.g. metallic and carbon-based particles) tend to display toxicity. However, the hazardous nature of certain nanomedicines could be exploited for the ablation of diseased tissue, if selective targeting can be achieved. This review discusses the mechanisms for molecular, cellular, organ, and immune system toxicity, which can be observed with a subset of nanoparticles. Strategies for improving the safety of nanoparticles by surface modification and pretreatment with immunomodulators are also discussed. Additionally, important considerations for nanoparticle safety assessment are reviewed. In regards to clinical application, stricter regulations for the approval of nanomedicines might not be required. Rather, safety evaluation assays should be adjusted to be more appropriate for engineered nanoparticles.
类目[WOS]Pharmacology & Pharmacy
收录类别SCI
WOS记录号WOS:000365624900012
引用统计
被引频次:25[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.ihep.ac.cn/handle/311005/228840
专题中国科学院高能物理研究所_多学科研究中心_期刊论文
推荐引用方式
GB/T 7714
Wolfram, J,Zhu, MT,Yang, Y,et al. Safety of Nanoparticles in Medicine[J]. CURRENT DRUG TARGETS,2015,16(14):1671-1681.
APA Wolfram, J.,Zhu, MT.,Yang, Y.,Shen, JL.,Gentile, E.,...&赵宇亮.(2015).Safety of Nanoparticles in Medicine.CURRENT DRUG TARGETS,16(14),1671-1681.
MLA Wolfram, J,et al."Safety of Nanoparticles in Medicine".CURRENT DRUG TARGETS 16.14(2015):1671-1681.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
793.pdf(1360KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wolfram, J]的文章
[Zhu, MT]的文章
[Yang, Y]的文章
百度学术
百度学术中相似的文章
[Wolfram, J]的文章
[Zhu, MT]的文章
[Yang, Y]的文章
必应学术
必应学术中相似的文章
[Wolfram, J]的文章
[Zhu, MT]的文章
[Yang, Y]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 793.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。